Motivational Enhancement Therapy's Impact on d COPD Outcomes in Geriatric Patient - Trial NCT06421896
Access comprehensive clinical trial information for NCT06421896 through Pure Global AI's free database. This phase not specified trial is sponsored by Alexandria University and is currently Recruiting. The study focuses on COPD. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Alexandria University
Timeline & Enrollment
N/A
Jun 01, 2024
Oct 01, 2024
Primary Outcome
COPD geriatric patients who entered motivational Enhancement Therapy will demonstrate a higher score in resilience scale ( ( total score range from 15 to 75, a higher score of more than 50)than those who not entered
Summary
Motivational Enhancement Therapy (MET) is a systematic intervention that focuses on eliciting
 and strengthening a person's intrinsic motivation to change. MET is rooted in motivational
 interviewing principles, emphasizing empathy, autonomy, and the evocation of the patient's
 own motivations for change. The therapy typically involves several sessions where therapists
 help patients identify personal goals, explore ambivalence towards change, and develop
 actionable plans to achieve their desired outcomes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06421896
Non-Device Trial